Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis
- PMID: 34824145
- DOI: 10.1136/jnnp-2021-327643
Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis
Keywords: autoimmune encephalitis; immunology; neuroimmunology.
Conflict of interest statement
Competing interests: SRI is a co-applicant and receive royalties on patent application WO/2010/046716 entitled ‘Neurological Autoimmune Disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. SRI is inventor on ‘A Diagnostic Strategy to improve specificity of CASPR2 antibody detection.’ Ref. JA94536P. SRI has received honoraria from UCB, Immunovant, Roche, Cerebral Therapeutics, MedImmun, ADC therapeutics, Medlink Neurology and research support from CSL Behring, UCB and ONO Pharma.
Comment on
-
LGI1 antibody encephalitis: acute treatment comparisons and outcome.J Neurol Neurosurg Psychiatry. 2022 Mar;93(3):309-315. doi: 10.1136/jnnp-2021-327302. Epub 2021 Nov 25. J Neurol Neurosurg Psychiatry. 2022. PMID: 34824144 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical